We partner with you on the front line of intensive care, so you can help deliver accurate and effective treatments with confidence.
Intensive care unit (ICU) patients under your care have the highest need for monitoring and treatment in the hospital, and they often have comorbidities1. We know caring for your ICU patients is often a race against the clock, and requires the latest innovations to support medication delivery, organ support and nutritional care.
We’re committed to being your partner with industry-leading technologies and services that support your ability to deliver multi-organ support in the ICU.
Acute kidney injury (AKI) is an increasingly common complication of acute illnesses in ICUs and hospitals2,3,4, with a reported 1.4 million AKI patients requiring renal replacement therapy5. As a leader in CRRT for more than 20 years, our advanced technology helps you manage patients with AKI. We also are committed to working alongside you to advance therapy options and provide comprehensive training and ongoing clinical and technical support.
Additionally, there are growing needs to manage organ support in combination or outside AKI. We’re committed to being your partner of choice with industry-leading technologies and services that support your ability to deliver multi-organ support in the ICU, including liver, blood purification and lung support outside the United States.
Advancing Global Critical Care
Access
Our continuous renal replacement technology is available in more than 80 countries, and in 29 languages.
Quality
Our CRRT technology can deliver a high standard of care when AKI occurs in the ICU; more than 7 million treatments have been provided globally.
Safety
Our CRRT technology is a highly accurate system that is built with safety features to help you closely monitor and manage patient care.
The PrisMax System
Our PrisMax System is designed to provide individualized care for critically ill patients in the intensive care unit (ICU) through the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies. The flexible system is compatible with a wide range of membranes for individual patient needs, including those with lower body weight. The PrisMax system also builds on our commitment to safety with integrated features that monitor therapy setup and delivery and may help reduce human error.
Rx Only. For safe and proper use of the PrisMax System, refer to the complete instructions in the Operator’s Manual or User’s Guide.
The innovative Prismaflex System is designed to support the recovery of critically ill patients with acute kidney injury (AKI). The flexible system meets the demands of multiple therapies with a versatile platform that can be customized to specific patient needs.
Its fluid algorithms help balance patient chemistry with fluid removal for optimal therapy delivery. You can monitor how much therapy the patient is receiving within 7 mL of effluent accuracy, at any given time.
When time is precious, Prismaflex may also help by providing automatic adjustments and immediate visual feedback about the treatment. With this system, you can spend your time serving, observing and caring for patients – not managing machines.
Rx Only. For safe and proper use of the Prismaflex System, refer to the complete instructions in the Operator’s Manual or User’s Guide.
The Oxiris set can be used with PrisMax and PrismaFlex systems, and is the only filter that performs multiple blood purification therapies simultaneously, including continuous renal replacement therapy (CRRT) and the removal of cytokines and inflammatory mediators from the blood.
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for the Oxiris filter to treat certain COVID-19 patients for no longer than the duration of the COVID-19 public health emergency.
The FDA has not cleared or approved the Oxiris set.